Novel synthetic analogues of avian β-defensin-12: the role of charge, hydrophobicity, and disulfide bridges in biological functions
暂无分享,去创建一个
[1] G. Rottinghaus,et al. Structure-function analysis of Avian β-defensin-6 and β-defensin-12: role of charge and disulfide bridges , 2016, BMC Microbiology.
[2] M. Otto,et al. Bacterial strategies of resistance to antimicrobial peptides , 2016, Philosophical Transactions of the Royal Society B: Biological Sciences.
[3] N. Malanovic,et al. Gram-positive bacterial cell envelopes: The impact on the activity of antimicrobial peptides. , 2016, Biochimica et biophysica acta.
[4] Vesna B. Medakovic,et al. C–H/O Interactions of Aromatic CH Donors within Proteins: A Crystallographic Study , 2016 .
[5] Ventola Cl,et al. The antibiotic resistance crisis: part 2: management strategies and new agents. , 2015, P & T : a peer-reviewed journal for formulary management.
[6] H. Yacoub,et al. Antimicrobial activities of chicken β-defensin (4 and 10) peptides against pathogenic bacteria and fungi , 2015, Front. Cell. Infect. Microbiol..
[7] C. L. Ventola. The antibiotic resistance crisis: part 1: causes and threats. , 2015, P & T : a peer-reviewed journal for formulary management.
[8] Qin Wang,et al. N-Terminus Three Residues Deletion Mutant of Human Beta-Defensin 3 with Remarkably Enhanced Salt-Resistance , 2015, PloS one.
[9] R. Nagaraj,et al. A Hybrid Cationic Peptide Composed of Human β-Defensin-1 and Humanized θ-Defensin Sequences Exhibits Salt-Resistant Antimicrobial Activity , 2014, Antimicrobial Agents and Chemotherapy.
[10] K. L. Nawrocki,et al. Antimicrobial Peptide Resistance Mechanisms of Gram-Positive Bacteria , 2014, Antibiotics.
[11] Li Zhao,et al. Expression, Purification, and In Vitro Comparative Characterization of Avian Beta-Defensin-2, -6, and -12 , 2014, Avian diseases.
[12] Guolong Zhang,et al. Avian Antimicrobial Host Defense Peptides: From Biology to Therapeutic Applications , 2014, Pharmaceuticals.
[13] F. Almeida,et al. Structural basis for the interaction of human β-defensin 6 and its putative chemokine receptor CCR2 and breast cancer microvesicles. , 2013, Journal of molecular biology.
[14] H. Haagsman,et al. Avian host defense peptides. , 2013, Developmental and comparative immunology.
[15] M. Ueda,et al. Characterization of Antimicrobial Peptides toward the Development of Novel Antibiotics , 2013, Pharmaceuticals.
[16] B. Yip,et al. Boosting Salt Resistance of Short Antimicrobial Peptides , 2013, Antimicrobial Agents and Chemotherapy.
[17] F. Moreau,et al. Colonic MUC2 mucin regulates the expression and antimicrobial activity of β-defensin 2 , 2015, Mucosal Immunology.
[18] Shengwang Liu,et al. Three novel Anas platyrhynchos avian β-defensins, upregulated by duck hepatitis virus, with antibacterial and antiviral activities. , 2011, Molecular immunology.
[19] C. Semple,et al. Human β-defensin 3 affects the activity of pro-inflammatory pathways associated with MyD88 and TRIF , 2011, European journal of immunology.
[20] T. Hehlgans,et al. Human β-Defensin 2 and 3 and Their Mouse Orthologs Induce Chemotaxis through Interaction with CCR2 , 2010, The Journal of Immunology.
[21] H. Kalbacher,et al. The Bacterial Defensin Resistance Protein MprF Consists of Separable Domains for Lipid Lysinylation and Antimicrobial Peptide Repulsion , 2009, PLoS pathogens.
[22] Soja Saghar Soman,et al. Immunomodulation by duck defensin, Apl_AvBD2: in vitro dendritic cell immunoreceptor (DCIR) mRNA suppression, and B- and T-lymphocyte chemotaxis. , 2009, Molecular immunology.
[23] R. Gallo,et al. AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense. , 2009, Trends in immunology.
[24] E. Veldhuizen,et al. Avian defensins , 2008, Veterinary Immunology and Immunopathology.
[25] R. Beuerman,et al. Defensins: Antimicrobial peptides for therapeutic development , 2007, Biotechnology journal.
[26] G. French,et al. Bactericidal agents in the treatment of MRSA infections--the potential role of daptomycin. , 2006, The Journal of antimicrobial chemotherapy.
[27] E. Soulsby. Resistance to antimicrobials in humans and animals , 2005, BMJ : British Medical Journal.
[28] B. Meyer,et al. Structure-activity relation of human beta-defensin 3: influence of disulfide bonds and cysteine substitution on antimicrobial activity and cytotoxicity. , 2005, Biochemistry.
[29] Reto Stöcklin,et al. Anti‐microbial peptides: from invertebrates to vertebrates , 2004, Immunological reviews.
[30] T. Foster,et al. Staphylococcus aureus Resists Human Defensins by Production of Staphylokinase, a Novel Bacterial Evasion Mechanism1 , 2004, The Journal of Immunology.
[31] Ann Eisenberg Shinnar,et al. Cathelicidin family of antimicrobial peptides: proteolytic processing and protease resistance. , 2003, Bioorganic chemistry.
[32] T. Ganz. Defensins: antimicrobial peptides of innate immunity , 2003, Nature Reviews Immunology.
[33] Jacek Lubkowski,et al. Antimicrobial Characterization of Human β-Defensin 3 Derivatives , 2003, Antimicrobial Agents and Chemotherapy.
[34] R. Nagaraj,et al. Single disulfide and linear analogues corresponding to the carboxy-terminal segment of bovine beta-defensin-2: effects of introducing the beta-hairpin nucleating sequence d-pro-gly on antibacterial activity and Biophysical properties. , 2003, Biochemistry.
[35] D. Hoover,et al. Engineering disulfide bridges to dissect antimicrobial and chemotactic activities of human β-defensin 3 , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[36] A. de Kruif,et al. Antimicrobial Resistance in Livestock , 2022 .
[37] D. Donoghue. Antibiotic residues in poultry tissues and eggs: human health concerns? , 2003, Poultry science.
[38] Michael R. Yeaman,et al. Mechanisms of Antimicrobial Peptide Action and Resistance , 2003, Pharmacological Reviews.
[39] R. Nagaraj,et al. Antibacterial activities and conformations of bovine β-defensin BNBD-12 and analogs:structural and disulfide bridge requirements for activity , 2002, Peptides.
[40] Ji Ming Wang,et al. β-Defensins: Linking Innate and Adaptive Immunity Through Dendritic and T Cell CCR6 , 1999 .
[41] W. Falk,et al. A 48-well micro chemotaxis assembly for rapid and accurate measurement of leukocyte migration. , 1980, Journal of immunological methods.
[42] V. Nizet,et al. Bacterial Evasion of Host Antimicrobial Peptide Defenses , 2016, Microbiology spectrum.
[43] C. L. Ventola,et al. The antibiotic resistance crisis: part 2: management strategies and new agents. , 2015, P & T : a peer-reviewed journal for formulary management.
[44] R. Nagaraj,et al. A hybrid cationic peptide composed of human beta-defensin-1 and , 2014 .
[45] R. Lehrer,et al. Primate defensins , 2004, Nature Reviews Microbiology.
[46] Jacek Lubkowski,et al. Antimicrobial characterization of human beta-defensin 3 derivatives. , 2003, Antimicrobial agents and chemotherapy.
[47] Mary Jane Ferraro,et al. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard , 2000 .